Amit Sachdev, EVP Chief Patient & Ext Af Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,364 shares at $486.35 ($1.6M) on 2026-02-25, disclosed to the SEC on 2026-02-26.
Scheduled sale ($1.6M) by EVP Chief Patient & Ext Af Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $485.11 | 1,518 | $736K | 45.1% |
| 2 | $486.35 | 1,846 | $898K | 54.9% |
| Total | $485.79 avg | 3,364 | $1.6M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $3.6M | — | Filing → |